Patients suffering from Crohn’s disease and ulcerative colitis in the Netherlands are reportedly facing dangerously long ...

The former teacher admitted she’s had “many” scary moments and her adventure across the world hasn’t always been easy. She’s ...

When Mark Wright was diagnosed with Crohn’s disease he was in the middle of high school, aged 15, he didn’t have a clue what ...

The dancer has been flooded with messages of praise and support as she made an announcement linked to suffering from an ...

Johnson & Johnson, with the endorsement of the Emirates Gastroenterology & Hepatology Society, has created the largest ...

Inflammatory bowel disease (IBD), encompassing Crohn's and Ulcerative Colitis, subtly manifests in infants through feeding ...

Scientists identify the complex interplay between immune dysfunction, genetics, environment and disease progression driving ...

It can cause a wide range of symptoms, from abdominal pain to arthritis. Symptoms tend to follow a relapsing-remitting ...

As recently as March, the FDA approved the IL-23 inhibitor guselkumab (Tremfya, Johnson & Johnson/Janssen) for patients with Crohn’s disease, offering both IV and subcutaneous induction options.

The use of digital health technology (DHT) is increasing worldwide. Clinical trials assessing available health tools for the ...

Wine may cause discomfort for people with gastrointestinal (GI) disorders, new research suggests. Though some evidence ...